In-vitro diagnostic, cytology, cancer
NOVACYT’s objectives are to save the lives of thousands of women around the world by providing major innovation in the diagnosis of cervical cancer, to develop a new business model that takes into account both social and medical issues, to focus its commercial development on emerging markets and to respect the environment.
Cancer screening is an issue of paramount importance for national health systems. It represents a large and growing market on which NOVACYT is already present. In order to respond to the increasing demand for better ways to diagnose cervical cancer, NOVACYT aims to continually enhance its effectiveness, to continue being innovative and to expand the reach of its products internationally – and especially in emerging markets with substantial demand.